BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22346746)

  • 1. Substance P causes seizures in neurocysticercosis.
    Robinson P; Garza A; Weinstock J; Serpa JA; Goodman JC; Eckols KT; Firozgary B; Tweardy DJ
    PLoS Pathog; 2012 Feb; 8(2):e1002489. PubMed ID: 22346746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection.
    Garza A; Weinstock J; Robinson P
    J Parasitol; 2008 Dec; 94(6):1253-8. PubMed ID: 18576810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis.
    Garza A; Tweardy DJ; Weinstock J; Viswanathan B; Robinson P
    J Biomed Biotechnol; 2010; 2010():597086. PubMed ID: 20150970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptogenic activity of granulomas associated with murine cysticercosis.
    Stringer JL; Marks LM; White AC; Robinson P
    Exp Neurol; 2003 Oct; 183(2):532-6. PubMed ID: 14552894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.
    Robinson P; White AC; Lewis DE; Thornby J; David E; Weinstock J
    Infect Immun; 2002 Aug; 70(8):4534-8. PubMed ID: 12117965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Centered Around Calcified Taenia solium Granuloma.
    Nash TE; Bustos JA; Garcia HH;
    Trends Parasitol; 2017 Jan; 33(1):65-73. PubMed ID: 27720140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of familial aggregation of seizures in neurocysticercosis patients.
    Kelvin EA; Carpio A; Hesdorffer DC; Bagiella E; Leslie D; Leon P; Andrews H; Hauser WA;
    Epilepsy Res; 2009 Mar; 84(1):67-71. PubMed ID: 19144499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis.
    Verma A; Prasad KN; Nyati KK; Singh SK; Singh AK; Paliwal VK; Gupta RK
    Parasitology; 2011 Sep; 138(11):1423-8. PubMed ID: 21813044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in the treatment of seizures associated with neurocysticercosis.
    Singh G; Sharma R
    Epilepsy Behav; 2017 Nov; 76():163-167. PubMed ID: 28673685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocysticercosis: new thoughts on controversial issues.
    Del Brutto OH
    Curr Opin Neurol; 2013 Jun; 26(3):289-94. PubMed ID: 23493161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Leukocyte Infiltration in Absence of Eosinophils Correlates with Decreased Tissue Damage and Disease Susceptibility in ΔdblGATA Mice during Murine Neurocysticercosis.
    Mishra PK; Li Q; Munoz LE; Mares CA; Morris EG; Teale JM; Cardona AE
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004787. PubMed ID: 27332553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features.
    Ooi WW; Wijemanne S; Thomas CB; Quezado M; Brown CR; Nash TE
    Am J Trop Med Hyg; 2011 Sep; 85(3):460-3. PubMed ID: 21896805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema.
    Fujita M; Mahanty S; Zoghbi SS; Ferraris Araneta MD; Hong J; Pike VW; Innis RB; Nash TE
    PLoS One; 2013; 8(9):e74052. PubMed ID: 24058514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin negatively regulates parasite burden and granulomatous responses in cysticercosis.
    Khumbatta M; Firozgary B; Tweardy DJ; Weinstock J; Firozgary G; Bhatena Z; Bulsara T; Siller R; Robinson P
    Biomed Res Int; 2014; 2014():247182. PubMed ID: 25530957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation.
    Sharma LN; Garg RK; Verma R; Singh MK; Malhotra HS
    Seizure; 2013 Dec; 22(10):840-5. PubMed ID: 23880307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for neurocysticercosis in children with a first-onset seizure in rural North India.
    Mital AK; Choudhary P; Jain RB
    Paediatr Int Child Health; 2020 Aug; 40(3):158-165. PubMed ID: 32204672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures.
    Patil S; Robinson P; Actor JK; Baig S; White AC
    J Parasitol; 2006 Aug; 92(4):738-41. PubMed ID: 16995390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Seizure Characteristics and Recurrence Rates in Children with Viable Parenchymal Neurocysticercosis and Tuberculoma in India.
    Panda PK; Ramachandran A; Sharawat IK; Sherwani P; Bhat NK
    Am J Trop Med Hyg; 2022 Oct; 107(4):833-840. PubMed ID: 36037862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice.
    Li Q; Wu X; Yang Y; Zhang Y; He F; Xu X; Zhang Z; Tao L; Luo C
    Int J Biochem Cell Biol; 2019 Feb; 107():154-165. PubMed ID: 30593954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.